Fresenius SE & Co. (FSNUY) to Release Quarterly Earnings on Wednesday

Fresenius SE & Co. (OTCMKTS:FSNUY) is anticipated to announce its resultson Wednesday, May 6th. Analysts expect the company to announce earnings of $0.2535 per share and revenue of $6.7899 billion for the quarter.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its quarterly earnings results on Wednesday, February 25th. The company reported $0.28 earnings per share (EPS) for the quarter. Fresenius SE & Co. had a return on equity of 10.31% and a net margin of 5.71%.The company had revenue of $6.94 billion during the quarter. On average, analysts expect Fresenius SE & Co. to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fresenius SE & Co. Trading Down 2.0%

Shares of FSNUY stock opened at $11.98 on Tuesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32. Fresenius SE & Co. has a 1 year low of $11.67 and a 1 year high of $33.93. The stock has a fifty day moving average of $13.27 and a two-hundred day moving average of $14.19. The firm has a market capitalization of $26.99 billion, a PE ratio of 19.02 and a beta of 0.68.

Analyst Ratings Changes

A number of research analysts have issued reports on FSNUY shares. Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.